VANDELLI, Maria Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.276
EU - Europa 17.605
AS - Asia 13.824
SA - Sud America 1.886
AF - Africa 257
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 28
Totale 68.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.947
GB - Regno Unito 6.024
CN - Cina 4.723
IT - Italia 4.622
SG - Singapore 4.021
HK - Hong Kong 2.036
SE - Svezia 1.853
BR - Brasile 1.494
DE - Germania 1.139
TR - Turchia 777
RU - Federazione Russa 758
UA - Ucraina 748
VN - Vietnam 627
FI - Finlandia 619
KR - Corea 436
FR - Francia 422
BG - Bulgaria 296
IN - India 278
NL - Olanda 202
CA - Canada 157
ID - Indonesia 157
AR - Argentina 147
JP - Giappone 138
IE - Irlanda 124
RO - Romania 111
PL - Polonia 103
ZA - Sudafrica 103
MX - Messico 97
BE - Belgio 96
ES - Italia 93
BD - Bangladesh 82
IQ - Iraq 74
EC - Ecuador 73
PK - Pakistan 69
LT - Lituania 61
CH - Svizzera 59
IR - Iran 55
AT - Austria 50
CO - Colombia 45
AE - Emirati Arabi Uniti 44
AU - Australia 41
CZ - Repubblica Ceca 38
MY - Malesia 37
IL - Israele 36
MA - Marocco 36
UZ - Uzbekistan 36
EG - Egitto 34
CL - Cile 32
LU - Lussemburgo 31
VE - Venezuela 31
PT - Portogallo 27
PE - Perù 24
EU - Europa 23
GR - Grecia 22
SA - Arabia Saudita 22
PY - Paraguay 19
TW - Taiwan 18
PH - Filippine 16
TN - Tunisia 16
HU - Ungheria 15
JO - Giordania 15
MD - Moldavia 15
TH - Thailandia 15
DZ - Algeria 14
KZ - Kazakistan 14
AZ - Azerbaigian 12
KE - Kenya 12
UY - Uruguay 12
AL - Albania 11
JM - Giamaica 11
NO - Norvegia 11
DK - Danimarca 10
SN - Senegal 10
NP - Nepal 9
NZ - Nuova Zelanda 9
BO - Bolivia 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
OM - Oman 8
AM - Armenia 7
EE - Estonia 7
LA - Repubblica Popolare Democratica del Laos 7
LB - Libano 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
PA - Panama 6
RS - Serbia 6
SI - Slovenia 6
BH - Bahrain 5
BZ - Belize 5
ET - Etiopia 5
GT - Guatemala 5
KH - Cambogia 5
LV - Lettonia 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
YE - Yemen 5
AN - Antille olandesi 4
Totale 68.849
Salva come PNG Salva come JPEG
Città #
Southend 4.606
Santa Clara 3.372
Ashburn 2.921
Fairfield 2.820
Singapore 2.472
Chandler 2.167
Woodbridge 2.027
Hong Kong 2.017
Hefei 1.711
Jacksonville 1.531
Houston 1.407
Chicago 1.233
Seattle 1.199
Wilmington 1.171
Dearborn 1.131
Ann Arbor 1.073
Nyköping 1.028
Cambridge 951
Los Angeles 826
Beijing 797
London 767
Modena 643
San Jose 633
Izmir 458
Salt Lake City 384
Seoul 358
New York 347
Helsinki 313
Princeton 313
The Dalles 301
Sofia 291
Council Bluffs 286
San Diego 267
Eugene 264
Dallas 255
Milan 242
Rome 218
Ho Chi Minh City 211
Bologna 205
Buffalo 204
Moscow 195
Redwood City 185
Des Moines 184
Shanghai 182
Elk Grove Village 165
Tampa 165
Munich 160
Hanoi 145
São Paulo 144
Bremen 124
Fremont 113
Jakarta 112
Dublin 106
Tokyo 102
Columbus 96
Reggio Emilia 93
Brussels 91
Lancaster 90
Frankfurt am Main 89
Boardman 82
Falls Church 81
Guangzhou 78
Miami 78
Sterling 75
Phoenix 73
Naples 66
Parma 65
Atlanta 61
Warsaw 60
Johannesburg 56
Stockholm 56
Como 53
Dulles 53
Brooklyn 52
Nanjing 51
Chennai 50
Denver 49
Turku 49
Norwalk 48
Orem 47
Turin 47
Detroit 46
Kent 46
Florence 43
Kunming 41
Bari 39
Montreal 39
Redondo Beach 38
Tulare 38
Rio de Janeiro 37
Catania 35
Toronto 35
Milwaukee 34
Zhengzhou 34
Istanbul 33
Jinan 33
Napoli 33
Amsterdam 32
Changsha 32
San Francisco 32
Totale 47.991
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 517
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 485
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 464
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 448
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 433
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 411
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 408
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 400
Cationic liposomes for gene transfection 394
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 394
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 394
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 391
The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions 391
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 388
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 386
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 385
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 384
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 381
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 379
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 375
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 374
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 373
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 372
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 365
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 359
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 359
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 354
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 352
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 348
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 346
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 343
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 336
A Metabolomic Approach Applied to a LiquidChromatography Coupled to High-ResolutionTandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the ComprehensiveEvaluation of the Chemical Composition ofCannabis Medicinal Extracts 335
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 334
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 333
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method 330
Distribution of drugs in polymers loaded by swelling 329
Polymeric nanoparticles for the drug delivery to the central nervous system 328
Brain targeting with polymeric nanoparticles: which administration route should we take? 327
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 325
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 322
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 319
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 318
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 317
Nanoparticle transport across the blood brain barrier 317
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 317
Microwave-treated gelatin microspheres as drug delivery system 315
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 315
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 314
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 308
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 306
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 305
Protein corona and nanoparticles: How can we investigate on? 305
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 303
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 301
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 300
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 298
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 297
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 296
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 294
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 294
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 293
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 289
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 289
Pharmaceutical and biomedical analysis of cannabinoids: A critical review 288
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 287
Bead coating process via an excess of crosslinking agent 285
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 284
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 284
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 284
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 282
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 282
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 281
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 280
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 279
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 278
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 278
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 277
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 275
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 275
Colloidal systems for CNS drug delivery 274
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 273
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 273
Properties of tolmetin-loaded Eudragit RL100 and Eudragit RS100 microparticles prepared by different techniques 272
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 272
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 270
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 267
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 265
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 264
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 263
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 262
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 262
Functionalization of liposomes: microscopical methods for preformulative screening 262
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 260
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 258
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 257
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 257
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 257
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 256
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 255
Totale 32.240
Salva come PNG Salva come JPEG
Categoria #
all - tutte 270.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 270.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.710 0 0 0 0 0 0 599 865 315 1.107 454 370
2021/20225.454 242 633 533 395 201 251 288 344 626 403 891 647
2022/20236.359 751 688 500 621 732 933 171 561 734 117 244 307
2023/20244.469 224 264 273 353 912 463 524 576 161 139 209 371
2024/202513.981 758 200 301 1.052 2.683 1.898 1.053 923 1.353 529 1.477 1.754
2025/202615.315 1.679 978 2.015 3.195 4.773 1.796 879 0 0 0 0 0
Totale 69.416